Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 10. August 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9030  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 180597  
   
Effect of Implementing Population-Based Prostate-Specific Antigen Screening on Testing Rates and Prostate Cancer Overdiagnosis in England: A Statistical Modelling Study.
Int J Cancer
Vickers AJ, Kasivisvanathan V, Brentnall AR.
PMID: 42572363 [PubMed - as supplied by publisher]


Thinking, Feeling, Choosing: How Affect Is Reflected in Prostate Cancer Treatment Decision Making-A Qualitative Study.
Psychooncology
Gong R, Alfonso N, Mossel AMV, Ordosgoitia MN, Montano JM, Jacques A Jr, Traeger L, Heller AS, Antoni MH, Crane TE, Gonzalgo ML, Mahal BA, Nahar B, Ritch C, Parekh DJ, Punnen S, Penedo FJ.
PMID: 42571713 [PubMed - indexed for MEDLINE]


Ten tips for kidney biopsy in cancer patients.
Clin Kidney J
Simeoni M, Ollero M, Garcia-Carro C, Bagnis C, Kousios A, van den Berg G, Soler MJ, Tesar V, Malyszko J.
PMID: 42571592 [PubMed]


Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.
Eur Urol Open Sci
Leenen RCA, Mulder EFH, Remmers S, de Vos II, Talala K, Hugosson J, Arnsrud-Godtman R, Hond ED, Villers A, Pionas G, Llane L, Lujan M, Gorini G, Puliti D, Kwiatkowski M, Wyler S, Bangma C, Schroder FH, Auvinen A, Roobol MJ, ERSPC Study Group.
PMID: 42571431 [PubMed]


A Pathology-Based Model for Postoperative Recurrence or Metastasis Prediction and Adjuvant Immunotherapy Implications of Clear-Cell Renal Cell Carcinoma: A Multicenter, Retrospective Study.
Ann Surg Oncol
Zhu Y, Ge L, Liu Z, Sun J, Wang X, Chu C, Zhao Z, Zhu Z, Shen H, Shi J, Liu G, Ji C, Zhang Q, Gan W, Zhang S, Jiang B, Guo H.
PMID: 42570984 [PubMed - as supplied by publisher]


Role of Cutibacterium acnes and Bacteroides fragilis in Prostate Cancer: a Turkish Population-Based Case-Control Study.
Clin Lab
Tokuc E, Gurses I, Aferin U, Ercili B, Gurbuz A, Erozenci NA, Bakar MT, Aksu O, Demirci M, Kurt Z, Ozturk-Bakar Y, Ceylan-Kilincarslan A, Ziyad MA, Turk S, Kocazeybek BS, Bahar-Tokman H.
PMID: 42570665 [PubMed - indexed for MEDLINE]


Prediction models for adverse events from prostate cancer curative radiotherapy: a systematic review of methodological quality.
Transl Oncol
Oliveira CC, Jongen CAM, Mikoli, Incrocci L, Lingsma HF, Roobol MJ, Korfage I, Heemsbergen WD, van Klaveren D, 4D PICTURE consortium.
PMID: 42570550 [PubMed - as supplied by publisher]


PSMA PET in Prostate Cancer: Clinical Value, Access Challenges, and Priorities for Implementation.
Eur Urol Oncol
Peyrottes A, Turpin L, Hernández LF, Rivas JG, Rouprêt M.
PMID: 42552166 [PubMed - as supplied by publisher]


Re: Emanuele Messina, Antonella Borrelli, Alessandro Sciarra, et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2025;89:246-57.
Eur Urol
Luca S, Ferrando L, Porpiglia F.
PMID: 42552153 [PubMed - as supplied by publisher]


Beyond the Trial: Can Audit and Feedback Produce Lasting Improvements in Transurethral Resection of Bladder Tumor Quality?
Fr J Urol
Mercier J, de la Taille A, Vordos D, Duquesne I.
PMID: 42551555 [PubMed - as supplied by publisher]


Mortality in Medicare-aged Men with Metastatic Prostate Cancer After the Introduction of Androgen Receptor Pathway Inhibitors: A Population-Based Study.
Urology
Kim IE Jr, Hartman R, Gandhi K, Nikita N, Banks J, Kelly WK, Keith SW, Kim IY, Lu-Yao G.
PMID: 42551541 [PubMed - as supplied by publisher]


Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.
Clin Adv Hematol Oncol
Lee MS, Shi CT, Kim TH, Morales Martinez GA, Vasdev R, Waddle M, Takahashi N, Boorjian SA, Khanna A.
PMID: 42550814 [PubMed - indexed for MEDLINE]


Efficacy, safety, and quality of life outcomes of [(177)Lu] Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: a GRADE-assessed systematic review, meta-analysis and trial sequential analysis.
Int Urol Nephrol
Mubarika M, Maaz M, Muhammad A, Emmama S, Mazhar Z, Khalid M, Kumari J, Alamin MH, Ayalew BD, Noor H, Hassan M, Khawar M, Sadiq MH, Syed GMS, Evangelista L, Bomanji J.
PMID: 42570199 [PubMed - as supplied by publisher]


Comparison of postoperative and early oncological outcomes of open versus robotic radical cystectomy.
J Robot Surg
Eleftheriou C, Zhao Y, Lami M, Boaz RJ, Moftah A, Jurdon K, Khan A, Gibbons N, Hellawell G, Bolton E, Heer R.
PMID: 42570123 [PubMed - indexed for MEDLINE]


Impact of surgical start time on clinical outcomes in urologic surgery: a single-center study of major oncologic surgeries and adrenalectomy.
World J Urol
Kobatake K, Goto K, Kohada Y, Naito M, Miyamoto S, Sekino Y, Kitano H, Hieda K, Hinata N.
PMID: 42570100 [PubMed - indexed for MEDLINE]


Autonomous AI in prostate cancer: the road ahead towards clinical implementation.
Abdom Radiol (NY)
Koopmans LD, Vega Lara F, Roest C, Turkbey B, Yakar D, Kwee TC.
PMID: 42570088 [PubMed - as supplied by publisher]


[Endoscopic Ultrasound-Guided Biopsy as a Minimally Invasive Diagnostic Tool for Mesorectal Metastasis From Clear Cell Renal Carcinoma: A Case Report].
Acta Gastroenterol Latinoam
Kahn NM, Defanti MF, Carlino YG.
PMID: 42569726 [PubMed]


Early outcomes of online adaptive MR-guided SBRT for localized prostate cancer: a prospective study.
Clin Transl Radiat Oncol
Ocanto A, González M, Teja M, Guardia G, Sánchez G, Gonsalves D, Fernández C, Torres L, Glaría L, Thuissard I, Gaztañaga M, García J, Romero Zhogbi SE, Andreescu J, Flores Á, Dzhugashvili M, Esteban D, Krumina E, Aaki L, Fernández J, González J, Ristori A, Begara J, Rivas D, Bravo J, Vílchez A, Clemente L, Martínez-Salamanca J, Nicosia L, Alongi F, Loblaw A, López-Campos F, Couñago F.
PMID: 42569367 [PubMed]


The addition of PSMA PET in selecting candidates for prostate cancer focal therapy.
BJUI Compass
Lim KY, Asghari-Jafarabadi M, Kalapara AA, Smith J, Frydenberg M, Ranasinghe W.
PMID: 42568760 [PubMed]


Adenomatoid tumor of the testis in a patient with history of cryptorchidism, male breast cancer, and thymic B2 thymoma: a case report and literature review.
Front Oncol
Cao Y, Zhang X, Song F, Liu L, Cui X, Li S, Li C, Su S.
PMID: 42568653 [PubMed]


   
   Artikel 1 - 20 / 180597    Seite 1 von 9030  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1